Experimental drug aims to save Insulin-Producing cells in new diabetes patients
NCT ID NCT07142252
Summary
This study is testing whether a new drug called rezpegaldesleukin can help preserve the body's remaining insulin production in people recently diagnosed with type 1 diabetes. Sixty-six participants, aged 8 to 45, will receive either the drug or a placebo injection every two weeks for six months, followed by six months of monitoring. The main goal is to see if the treatment helps protect the pancreas cells that make insulin.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vanderbilt University
Nashville, Tennessee, 37232, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.